Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Gongwin Biopharm Holdings Co., Ltd. (6617) Financial Statements

Gongwin Biopharm Holdings Co., Ltd. Financial Overview

Gongwin Biopharm Holdings Co., Ltd.'s market cap is currently NT$15.11B. The company's EPS TTM is NT$-1.35; its P/E ratio is -89.26; Gongwin Biopharm Holdings Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Mar 24Mar 23Dec 21
Income Statement
Total RevenueNT$ 36.45MNT$ 32.04MNT$ 18.91MNT$ 1.14MNT$ 1.14M
Gross ProfitNT$ 14.99MNT$ 8.68MNT$ 11.20MNT$ 1.07MNT$ 1.08M
Operating IncomeNT$ -207.29MNT$ -162.06MNT$ -133.33MNT$ -288.95MNT$ -113.54M
EBITDANT$ -196.19MNT$ -75.97MNT$ -81.05MNT$ -275.56MNT$ -100.58M
Net IncomeNT$ -114.13MNT$ -82.55MNT$ -92.04MNT$ -254.19MNT$ -121.58M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.82BNT$ 2.39BNT$ 1.08BNT$ 1.32BNT$ 909.82M
Total AssetsNT$ 2.80BNT$ 3.38BNT$ 1.52BNT$ 1.62BNT$ 1.17B
Total DebtNT$ 129.74MNT$ 126.75MNT$ 77.17MNT$ 141.74MNT$ 115.14M
Net DebtNT$ -839.16MNT$ -766.72MNT$ -196.42MNT$ -529.77MNT$ -338.98M
Total LiabilitiesNT$ 279.20MNT$ 281.84MNT$ 203.53MNT$ 248.70MNT$ 184.43M
Stockholders' EquityNT$ 2.53BNT$ 3.11BNT$ 1.32BNT$ 1.39BNT$ 970.72M
Cash Flow
Free Cash FlowNT$ -138.21MNT$ -293.54MNT$ -111.93MNT$ -238.37MNT$ -95.56M
Operating Cash FlowNT$ -135.75MNT$ -87.41MNT$ -110.80MNT$ -232.20MNT$ -95.51M
Investing Cash FlowNT$ 600.68MNT$ -1.20BNT$ -280.97MNT$ -202.00MNT$ -246.42M
Financing Cash FlowNT$ -388.61MNT$ 1.88BNT$ -12.10MNT$ 604.05MNT$ 101.77M

Currency in TWD

Gongwin Biopharm Holdings Co., Ltd. Earnings and Revenue History

-300M-150M0150M-60000 %-40000 %-20000 %0 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

Gongwin Biopharm Holdings Co., Ltd. Liabilities to Assets

01.2B2.4B3.6B5 %10 %15 %20 %LiabilitiesLiabilities to Assets2019202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

Gongwin Biopharm Holdings Co., Ltd. Cash Flow

-2B-1B01B2B3B2019202020212022202320242025OperatingInvestingFinancing
Cash Flow >

Gongwin Biopharm Holdings Co., Ltd. Forecast EPS vs Actual EPS

-0.4-0.4-0.3-0.3-0.2-0.2-0.1-0.1Q2 25Q3 25Q4 25Q1 26Q3 26EPS EstimateBeatMiss
Earnings >